Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Bruker Corporation designs, manufactures, and markets proprietary life science systems based on spectrometry technology platforms. The Company also sells a range of field analytical systems for substance detection and pathogen identification. Bruker develops life science and advanced materials research tools based on X-ray technology.
Website: bruker.com



Growth: Good revenue growth rate 20.6%, there is acceleration compared to average historical growth rates 15.0%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -0.8%

Profitability: LTM EBITDA margin is positive, +18.6%. On average the margin is decreasing unsteadily. Gross margin is high, +50.1%. In the last quarter the company beat the estimated EPS, +16.4%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.2%. Free cash flow yield -0.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 68.1% higher than minimum and 12.8% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.3x by EV / Sales multiple , the company can be 26.4% overvalued

Insiders: For the last 3 months insiders sold company shares on $5.0 mln (-0.039% of cap.)

Key Financials (Download financials)

Ticker: BRKR
Share price, USD:  (-0.3%)82.2
year average price 72.44  


year start price 78.27 2023-04-27

min close price 54.91 2023-10-30

max close price 94.27 2024-03-21

current price 82.20 2024-04-25
Common stocks: 149 255 013

Dividend Yield:  0.2%
FCF Yield LTM: -0.4%
EV / LTM EBITDA: 23.7x
EV / EBITDA annualized: 23.2x
Last revenue growth (y/y):  20.6%
Last growth of EBITDA (y/y):  -9.0%
Historical revenue growth:  15.0%
Historical growth of EBITDA:  31.4%
EV / Sales: 4.4x
Margin (EBITDA LTM / Revenue): 18.6%
Fundamental value created in LTM:
Market Cap ($m): 12 269
Net Debt ($m): 812
EV (Enterprise Value): 13 081
Price to Book: 8.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-17GeekWire

Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

2024-04-09Zacks Investment Research

Bruker (BRKR) Introduces Magnet Technology for NMR Adoption

2024-03-22Zacks Investment Research

Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

2024-03-14Zacks Investment Research

Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?

2024-03-14Zacks Investment Research

Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?

2024-03-12Zacks Investment Research

Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO

2024-03-05Zacks Investment Research

Here's Why Investors Should Retain Bruker (BRKR) Stock Now

2024-03-01Zacks Investment Research

Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup

2024-02-26Zacks Investment Research

Bruker's (BRKR) New Launches Drive Growth Amid FX Woes

2024-02-20Zacks Investment Research

2 Instruments Stocks to Buy From a Prospering Industry
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-29 2023-11-09 2023-08-09 2023-05-10 2022-12-31 2022-11-04
acceptedDate 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 855M 743M 682M 685M 708M 639M
costOfRevenue 426M 360M 341M 326M 343M 304M
grossProfit 428M 383M 341M 360M 366M 335M
grossProfitRatio 0.501 0.515 0.499 0.525 0.517 0.525
researchAndDevelopmentExpenses 83M 71M 71M 69M 64M 56M
generalAndAdministrativeExpenses 518M 178M 178M 163M 168M 145M
sellingAndMarketingExpenses -313M 0 0 0 -3M 0
sellingGeneralAndAdministrativeExpenses 205M 178M 178M 163M 165M 145M
otherExpenses -32M -9M -5M -5M -7M 0
operatingExpenses 321M 249M 249M 232M 228M 201M
costAndExpenses 747M 609M 590M 557M 571M 505M
interestIncome 137M 2M 2M 1M 0 0
interestExpense -7M -5M -9M -16M -3M -2M
depreciationAndAmortization 37M 27M 26M 30M 30M 24M
ebitda 145M 161M 118M 153M 161M 155M
ebitdaratio 0.170 0.216 0.172 0.223 0.228 0.243
operatingIncome 108M 125M 86M 123M 131M 131M
operatingIncomeRatio 0.126 0.168 0.126 0.179 0.185 0.206
totalOtherIncomeExpensesNet 133M -9M -5M -16M -10M -2M
incomeBeforeTax 241M 119M 78M 107M 121M 129M
incomeBeforeTaxRatio 0.282 0.160 0.114 0.156 0.171 0.202
incomeTaxExpense 37M 31M 20M 30M 23M 41M
netIncome 206M 88M 57M 77M 97M 88M
netIncomeRatio 0.240 0.119 0.084 0.112 0.137 0.138
eps 1.410 0.600 0.390 0.520 0.660 0.600
epsdiluted 1.410 0.600 0.390 0.520 0.660 0.590
weightedAverageShsOut 146M 147M 147M 147M 147M 148M
weightedAverageShsOutDil 146M 147M 148M 148M 148M 149M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-29 2023-11-09 2023-08-09 2023-05-10 2022-12-31 2022-11-04
acceptedDate 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 488M 364M 575M 598M 646M 626M
shortTermInvestments 12M 19M 0 0 -21M 0
cashAndShortTermInvestments 488M 364M 575M 598M 646M 626M
netReceivables 622M 485M 451M 472M 473M 421M
inventory 968M 916M 915M 859M 804M 750M
otherCurrentAssets 86M 264M 243M 208M 203M 240M
totalCurrentAssets 2 164M 2 029M 2 183M 2 136M 2 125M 2 037M
propertyPlantEquipmentNet 691M 527M 523M 511M 487M 422M
goodwill 583M 561M 558M 527M 458M 382M
intangibleAssets 331M 292M 300M 299M 271M 214M
goodwillAndIntangibleAssets 913M 1 262M 1 151M 1 117M 1 007M 879M
longTermInvestments 8M 19M 0 0 0 0
taxAssets 297M -410M 0 0 77M 0
otherNonCurrentAssets 176M 391M 0 0 -77M 0
totalNonCurrentAssets 2 086M 1 789M 1 674M 1 628M 1 494M 1 300M
otherAssets 0 0 0 0 0 0
totalAssets 4 250M 3 818M 3 857M 3 764M 3 619M 3 337M
accountPayables 203M 182M 189M 196M 182M 158M
shortTermDebt 145M 121M 121M 120M 19M 17M
taxPayables 139M 0 0 0 104M 0
deferredRevenue 400M 381M 397M 401M 226M 176M
otherCurrentLiabilities 455M 389M 344M 334M 487M 514M
totalCurrentLiabilities 1 202M 1 072M 1 051M 1 052M 914M 865M
longTermDebt 1 145M 1 099M 1 123M 1 109M 1 201M 1 137M
deferredRevenueNonCurrent 92M 0 0 0 56M 0
deferredTaxLiabilitiesNonCurrent 68M 0 0 0 62M 0
otherNonCurrentLiabilities 331M 403M 421M 392M 254M 1 168M
totalNonCurrentLiabilities 1 635M 1 502M 1 544M 1 501M 1 573M 1 519M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 91M 20M 0 0 51M 0
totalLiabilities 2 837M 2 574M 2 594M 2 553M 2 487M 2 383M
preferredStock 0 0 0 0 0 0
commonStock 2M 2M 2M 2M 2M 2M
retainedEarnings 2 324M 0 0 0 1 926M 0
accumulatedOtherComprehensiveIncomeLoss 6M -5M 24M 30M 15M -92M
othertotalStockholdersEquity -954M 1 231M 1 225M 1 168M -817M 1 038M
totalStockholdersEquity 1 377M 1 227M 1 251M 1 199M 1 126M 948M
totalEquity 1 413M 1 244M 1 263M 1 199M 1 126M 948M
totalLiabilitiesAndStockholdersEquity 4 250M 3 818M 3 857M 3 764M 3 619M 3 337M
minorityInterest 36M 17M 12M 12M 6M 0
totalLiabilitiesAndTotalEquity 4 250M 3 818M 3 857M 3 764M 3 619M 3 337M
totalInvestments 8M 19M 0 0 -21M 0
totalDebt 1 380M 1 220M 1 243M 1 229M 1 219M 1 154M
netDebt 891M 856M 669M 631M 574M 528M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-29 2023-11-09 2023-08-09 2023-05-10 2022-12-31 2022-11-04
acceptedDate 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 206M 89M 58M 77M 98M 88M
depreciationAndAmortization 37M 27M 26M 25M 24M 21M
deferredIncomeTax -37M 3M 8M 1M 9M -18M
stockBasedCompensation 6M 6M 6M 5M 5M 5M
changeInWorkingCapital 121M -85M -100M -24M 27M -36M
accountsReceivables 12M -43M 22M 8M -28M -35M
inventory 22M -34M -59M -55M -1 000 000 -35M
accountsPayables 12M 14M -17M 14M 29M 18M
otherWorkingCapital 76M -23M -47M 9M 28M 17M
otherNonCashItems -128M 5M 16M 2M -4M 8M
netCashProvidedByOperatingActivities 206M 44M 13M 88M 159M 70M
investmentsInPropertyPlantAndEquipment -32M -27M -24M -25M -24M -58M
acquisitionsNet -5M -120M -3M -88M -94M -100 000
purchasesOfInvestments -6M -10M -1M -8M -21M -3M
salesMaturitiesOfInvestments 3M 1M 1M 2M 1M 3M
otherInvestingActivites 1M 200 000 0 11M 100 000 0
netCashUsedForInvestingActivites -37M -155M -26M -108M -137M -58M
debtRepayment -6M -6M -6M -6M -4M -1M
commonStockIssued 5M 2M 2M 700 000 2M -3M
commonStockRepurchased -50M -80M 3M -22M -26M -73M
dividendsPaid -7M -7M -7M -7M -7M -7M
otherFinancingActivites -500 000 -1M -2M 4M -600 000 2M
netCashUsedProvidedByFinancingActivities -59M -93M -10M -31M -36M -82M
effectOfForexChangesOnCash 16M -8M 100 000 4M 33M -27M
netChangeInCash 125M -211M -23M -47M 19M -97M
cashAtEndOfPeriod 488M 367M 578M 601M 649M 629M
cashAtBeginningOfPeriod 364M 578M 601M 649M 629M 726M
operatingCashFlow 206M 44M 13M 88M 159M 70M
capitalExpenditure -32M -27M -24M -25M -24M -58M
freeCashFlow 174M 17M -11M 63M 135M 12M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-13 ET (fiscal 2023 q4)
2023 q3
2023-11-03 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-06 ET (fiscal 2023 q1)
2022 q4
2023-02-09 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-13 12:00 ET
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-07 12:00 ET
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
2024-02-06 21:05 ET
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
2024-02-06 12:00 ET
Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
2024-02-05 12:00 ET
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
2024-01-25 12:00 ET
Bruker Announces Agreement to Acquire Chemspeed
2024-01-23 13:30 ET
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
2024-01-23 13:00 ET
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
2024-01-04 13:00 ET
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
2024-01-03 21:35 ET
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-03 12:00 ET
Bruker Acquires Electron Microscopy Company Nion
2023-12-19 14:41 ET
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science Foundation
2023-11-20 21:15 ET
Bruker Announces Quarterly Dividend
2023-11-07 14:00 ET
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference
2023-11-02 11:00 ET
Bruker Reports Third Quarter 2023 Financial Results
2023-10-27 15:07 ET
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
2023-10-04 11:00 ET
Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)
2023-10-03 11:00 ET
Bruker Completes Acquisition of PhenomeX
2023-10-02 20:05 ET
Bruker Introduces Next-Generation Nanomechanical Test System
2023-09-18 11:00 ET
Bruker Introduces Novel 4D-Proteomics™ timsTOF® Capabilities
2023-09-15 08:06 ET
Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress
2023-09-07 11:00 ET
Bruker Announces New Fraport AG Framework Contract for ETD Systems
2023-09-06 11:43 ET
Dragonfly Energy Leverages Cutting-Edge Lithium Battery Research Instrumentation from Bruker
2023-09-05 20:02 ET
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
2023-08-24 20:05 ET
Bruker Corporation to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
2023-08-17 13:00 ET
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
2023-08-16 20:05 ET
Bruker to Provide 60 Explosives Trace Detectors for Zuerich Airport
2023-08-14 11:00 ET
Bruker Announces Quarterly Dividend
2023-08-03 11:00 ET
Bruker Reports Second Quarter 2023 Financial Results
2023-07-25 20:44 ET
Bruker Announces Date and Time of Second Quarter 2023 Earnings Release and Webcast
2023-07-10 11:00 ET
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
2023-06-30 11:00 ET
Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
2023-06-27 14:00 ET
Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research
2023-06-14 14:39 ET
Bruker Releases 2023 Sustainability Report
2023-06-05 11:00 ET
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™
2023-06-05 11:00 ET
Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments
2023-06-05 11:00 ET
PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS
2023-06-02 11:00 ET
Bruker Corporation to Present at Jefferies 2023 Healthcare Conference
2023-05-31 20:33 ET
Bruker to Host Investor Day on June 15th, 2023
2023-05-15 20:05 ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
2023-05-08 11:00 ET
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
2023-05-04 11:00 ET
Bruker Reports First Quarter 2023 Financial Results
2023-04-26 20:05 ET
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
2023-04-17 11:00 ET
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
2023-04-14 11:00 ET
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
2023-04-14 11:00 ET
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
2023-04-12 11:00 ET
Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
2023-03-17 11:00 ET
Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
2023-03-06 15:30 ET
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
2023-02-28 07:00 ET
CORRECTING and REPLACING The European Gauss Fusion Initiative Seeks to Use Magnetic Fusion to Ensure a Clean and Safe Energy Supply
2023-02-22 21:15 ET
Bruker Corporation to Present at Investor Conferences
2023-02-17 12:00 ET
Bruker Announces Quarterly Dividend
2023-02-09 12:00 ET
Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
2023-02-03 12:00 ET
Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
2023-01-31 21:05 ET
Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
2023-01-05 21:34 ET
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
2023-01-04 12:00 ET
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
2023-01-04 12:00 ET
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
2022-12-21 21:05 ET
Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-16 14:47 ET
Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies
2022-11-14 12:00 ET
Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
2022-11-11 12:00 ET
Bruker Announces Quarterly Dividend
2022-11-08 12:00 ET
Bruker Announces Acquisition of Inscopix for Neuroscience Research
2022-11-07 21:01 ET
Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
2022-11-03 11:00 ET
Bruker Reports Third Quarter 2022 Financial Results
2022-10-21 20:01 ET
Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
2022-08-29 10:00 ET
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software
2022-08-22 11:00 ET
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
2022-08-12 11:00 ET
Bruker Announces Quarterly Dividend
2022-08-03 20:01 ET
Bruker Reports Second Quarter 2022 Financial Results
2022-07-25 20:01 ET
Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast
2022-07-20 13:00 ET
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
2022-07-11 10:00 ET
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
2022-07-06 11:00 ET
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
2022-06-21 11:00 ET
Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
2022-06-21 10:00 ET
Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022
2022-06-14 11:00 ET
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
2022-06-06 11:00 ET
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
2022-06-06 11:00 ET
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
2022-06-06 11:00 ET
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™
2022-05-25 20:01 ET
Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference
2022-05-16 11:00 ET
Bruker Announces Quarterly Dividend
2022-05-10 11:00 ET
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets
2022-05-09 16:52 ET
Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
2022-05-04 11:00 ET
Bruker Reports First Quarter Financial Results
2022-04-25 11:00 ET
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet
2022-04-22 11:00 ET
Bruker Launches Unique LiquidArray® Multiplex PCR Assays
2022-04-18 20:05 ET
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast
2022-04-11 14:24 ET
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
2022-04-06 15:00 ET
IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development
2022-04-05 11:00 ET
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
2022-04-04 11:10 ET
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR
2022-03-16 13:46 ET
Bruker Appoints Philip Ma to its Board of Directors
2022-03-10 14:40 ET
Announcing New Fourier 80 Benchtop FT-NMR Capabilities for Pharmaceutical and Food Analysis Markets
2022-03-03 19:00 ET
Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution
2022-03-02 16:15 ET
Newomics and Bruker Announce Collaborations on High-throughput Bioanalysis
2022-02-28 16:05 ET
Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software
2022-02-28 12:00 ET
Bruker Corporation to Present at Cowen’s 42nd Annual Health Care Conference
2022-02-18 12:00 ET
Bruker Announces Quarterly Dividend
2022-02-11 12:00 ET
Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results
2022-02-10 12:00 ET
Bruker Corporation to Present at the 11th Annual SVB Leerink Global Healthcare Conference
2022-02-07 16:01 ET
IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research
2022-02-07 12:01 ET
Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform
2022-02-07 12:00 ET
Bruker Launches New timsTOF-based MALDI PharmaPulse® Solution for Label-free HTS in Drug Discovery
2022-02-04 12:00 ET
Bruker Expands Nanoflow Consumables Portfolio for 4D-Proteomics™
2022-02-02 12:00 ET
Bruker Announces Date and Time of Fourth Quarter 2021 Earnings Release and Webcast
2022-01-19 12:00 ET
Bruker Acquires Prolab Instruments to Augment Multiomics Solutions
2022-01-04 12:00 ET
Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021-12-20 12:00 ET
Bruker Introduces Fast BioAFM for Automated Mechanobiology
2021-12-08 12:00 ET
Bruker Announces $500 Million Private Placement of Senior Notes to Support Strategic Growth Objectives
2021-12-02 16:43 ET
Bruker Expects its FluoroType® SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentatively Differentiate Omicron (B.1.1.529) Variant
2021-11-19 12:00 ET
Bruker Announces Acquisition of MOLECUBES NV
2021-11-16 12:00 ET
Bruker Announces Collaborative Advances in CCS-Enabled 4D Proteomics Workflows at HUPO
2021-11-15 12:00 ET
Bruker Announces Fourth Quarter 2021 Dividend
2021-11-09 12:00 ET
Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference
2021-11-02 11:00 ET
Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS
2021-11-01 20:05 ET
Bruker Reports Third Quarter 2021 Financial Results
2021-10-18 20:10 ET
Bruker Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast
2021-10-01 11:00 ET
NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research
2021-08-30 20:10 ET
Bruker Corporation to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
2021-08-06 11:00 ET
Bruker Announces Quarterly Dividend
2021-08-02 20:05 ET
Bruker Reports Second Quarter 2021 Financial Results
2021-07-21 11:00 ET
Bruker Announces Date and Time of Second Quarter 2021 Earnings Release and Webcast
2021-06-21 12:00 ET
Novel 4D-Metabolomics and 4D-Lipidomics Workflows, Libraries and ML-based CCS Prediction Tools to Transform Metabolomics and Lipidomics
2021-06-17 12:00 ET
Bruker Updates FY 2021 Guidance and Provides Medium Term Outlook at Virtual Investor Day
2021-06-07 12:00 ET
Bruker to Host Virtual Investor Day on June 17th, 2021
2021-06-07 11:00 ET
Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation
2021-06-01 11:00 ET
Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth
2021-05-20 14:12 ET
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
2021-05-13 12:00 ET
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend
2021-05-10 11:14 ET
International Organization of Vine and Wine (OIV) Officially Incorporates NMR Method in Compendium of International Methods of Analysis of Wines and Musts
2021-05-07 11:00 ET
Bruker Corporation to Present at Investor Conferences
2021-05-05 11:00 ET
Bruker Reports First Quarter 2021 Financial Results
2021-04-13 20:10 ET
Bruker Announces First Quarter 2021 Preliminary Revenue
2021-03-29 13:00 ET
Cambridge Isotope Laboratories, Inc and Bruker Biospin Announce Strategic Partnership for the Global Distribution of CIL's NMR Solvents
2021-03-29 11:00 ET
Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research
2021-03-26 11:00 ET
Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs
2021-03-24 11:00 ET
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center
2021-03-18 11:00 ET
Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics
2021-03-10 21:59 ET
GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-Based Assays for Liver Fibrosis, Cirrhosis and Liver Cancer (HCC)
2021-03-08 14:22 ET
Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021
2021-02-25 13:41 ET
New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics
2021-02-22 12:00 ET
Bruker Corporation to Present at Investor Conferences
2021-02-18 12:00 ET
Bruker Announces Quarterly Dividend
2021-02-16 12:00 ET
Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
2021-02-02 21:05 ET
Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast
2021-01-28 09:19 ET
Avacta Announces Collaboration Agreement With Bruker
2021-01-07 12:00 ET
GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology
2021-01-06 12:00 ET
Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-05 12:00 ET
Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
2021-01-04 12:00 ET
Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures
2020-12-18 12:00 ET
Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark
2020-11-16 12:30 ET
Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference
2020-11-13 12:00 ET
Bruker Announces Quarterly Dividend
2020-11-02 21:05 ET
Bruker Reports Third Quarter 2020 Financial Results
2020-10-21 11:00 ET
Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities
2020-10-20 11:00 ET
Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and Webcast
2020-10-19 11:00 ET
Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System
2020-10-19 10:00 ET
Bruker Introduces PaSER™ Software for ‘Run and Done’ 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award
2020-09-30 11:00 ET
Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies
2020-09-11 11:00 ET
Bruker Announces Acquisition of Canopy Biosciences, LLC
2020-09-08 11:00 ET
Bruker Appoints Bonnie H. Anderson to its Board of Directors
2020-09-04 11:00 ET
Bruker Corporation to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
2020-08-10 11:00 ET
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins
2020-08-07 12:00 ET
Bruker Announces Quarterly Dividend
2020-08-07 11:00 ET
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
2020-08-03 20:05 ET
Bruker Reports Second Quarter 2020 Financial Results
2020-07-30 11:00 ET
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
2020-07-27 11:00 ET
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe
2020-07-22 12:30 ET
Successful Installation of ETH 1.2 GHz NMR System Enables Novel Research Capabilities in Solid-State NMR
2020-07-20 20:10 ET
Bruker Announces Date and Time of Second Quarter 2020 Earnings Release and Webcast
2020-07-10 09:00 ET
Inscopix Announces Collaboration With Bruker for Advanced Analysis of Brain Circuits by Combining Miniature Microscopes With Multiphoton Microscopy
2020-05-29 11:00 ET
Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF
2020-05-13 11:00 ET
Bruker Announces Quarterly Dividend
2020-05-12 20:10 ET
Bruker Corporation to Present at Virtual Investor Conferences
2020-05-11 12:00 ET
Bruker Announces Virtual Meeting Option for the Company’s 2020 Annual Stockholders Meeting
2020-05-06 20:05 ET
Bruker Reports First Quarter 2020 Financial Results
2020-05-04 11:00 ET
Successful Installation of World’s First 1.2 GHz NMR System Enables Novel Functional Structural Biology Research
2020-04-22 11:00 ET
Bruker Announces Date and Time of First Quarter 2020 Earnings Release and Webcast
2020-04-01 11:00 ET
Bruker Highlights New Analytical Systems and Applied Market Solutions
2020-03-27 21:05 ET
Bruker Announces Final Fourth Quarter and Fiscal Year 2019 Financial Results
2020-03-24 20:05 ET
Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus
2020-03-09 11:00 ET
New Functional Structural Biology Capabilities Enabled by Bruker GHz-Class NMR Technology
2020-01-28 12:00 ET
Bruker Announces Date and Time of Fourth Quarter 2019 Earnings Release and Webcast
2019-12-12 13:33 ET
Bruker Completes Debt Financing to Support Corporate Strategic Objectives
2019-11-15 12:00 ET
Bruker Corporation to Present at Investor Conferences
2019-11-14 12:00 ET
Bruker Announces Quarterly Dividend
2019-10-31 20:05 ET
Bruker Reports Third Quarter 2019 Financial Results
2019-10-21 11:00 ET
Bruker Announces Date and Time of Third Quarter 2019 Earnings Release and Webcast
2019-10-02 11:00 ET
Bruker Announces Acquisition of Magnettech's EPR Business
2019-09-20 11:00 ET
Strategic Alliance between Murdoch University and Bruker Supports International Centre of Excellence in Metabolic Phenotyping
2019-09-16 08:00 ET
Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF(TM) Pro Platform at HUPO 2019
2019-09-11 11:00 ET
Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser
2019-09-02 11:00 ET
Bruker Launches Highest Resolution Large-Format Bio-AFM System
2019-08-26 11:00 ET
Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data
2019-08-12 11:00 ET
Bruker Announces Quarterly Dividend
2019-08-01 20:05 ET
Bruker Reports Second Quarter 2019 Financial Results
2019-07-23 20:05 ET
Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast
2019-07-17 11:00 ET
Bruker Comments on Block Trade Transaction
2019-07-08 11:00 ET
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC
2019-06-20 11:00 ET
Bruker Launches MALDI Biotyper Sirius at ASM Microbe Conference
2019-06-14 11:00 ET
Bruker to Host Investor Day on June 20th, 2019
2019-05-31 16:54 ET
Bruker Launches timsTOF fleX(TM)  with ESI and MALDI for SpatialOMx(TM)
2019-05-28 19:00 ET
Bruker Corporation to Present at Jefferies 2019 Global Healthcare Conference
2019-05-13 11:00 ET
Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
2019-05-10 11:00 ET
Bruker Announces New $300 Million Share Repurchase Authorization and Quarterly Dividend
2019-05-02 20:06 ET
Bruker Reports First Quarter 2019 Financial Results
2019-04-23 11:00 ET
Bruker Announces Date and Time of First Quarter 2019 Earnings Release and Webcast
2019-04-15 11:00 ET
Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases
2019-04-08 11:00 ET
Bruker Announces World's First Superconducting 1.1 Gigahertz Magnet for High-Resolution NMR in Structural Biology
2019-04-03 11:00 ET
Bruker Announces Acquisition of RAVE LLC

SEC forms

Show financial reports only

SEC form 10
2024-02-29 00:00 ET
Bruker published news for 2023 q4
SEC form 8
2024-02-13 00:00 ET
Bruker published news for 2023 q4
SEC form 8
2024-02-13 00:00 ET
Bruker reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Bruker published news for 2023 q4
SEC form 10
2023-11-09 00:00 ET
Bruker published news for 2023 q3
SEC form 8
2023-11-02 07:00 ET
Bruker reported for 2023 q3
SEC form 10
2023-08-09 00:00 ET
Bruker published news for 2023 q2
SEC form 6
2023-08-03 07:01 ET
Bruker reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Bruker published news for 2023 q2
SEC form 6
2023-06-07 17:16 ET
Bruker published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Bruker published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Bruker published news for 2023 q1
SEC form 10
2023-03-01 00:00 ET
Bruker reported for 2022 q4
SEC form 8
2023-02-09 00:00 ET
Bruker reported for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Bruker published news for 2022 q4
SEC form 10
2022-11-04 00:00 ET
Bruker reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Bruker reported for 2022 q3
SEC form 10
2022-08-05 00:00 ET
Bruker reported for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Bruker reported for 2022 q2
SEC form 10
2022-05-06 00:00 ET
Bruker reported for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Bruker reported for 2022 q1
SEC form 10
2022-02-28 00:00 ET
Bruker published news for 2021 q4
SEC form 8
2022-02-11 00:00 ET
Bruker published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Bruker published news for 2021 q4
SEC form 10
2021-11-05 00:00 ET
Bruker published news for 2021 q3
SEC form 8
2021-11-01 00:00 ET
Bruker published news for 2021 q3
SEC form 10
2021-08-05 00:00 ET
Bruker published news for 2021 q2
SEC form 8
2021-08-02 00:00 ET
Bruker published news for 2021 q2
SEC form 10
2021-05-10 00:00 ET
Bruker published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Bruker published news for 2021 q1
SEC form 8
2021-04-13 00:00 ET
Bruker published news for 2021 q1